- Home
- NSPR vs ONCY Comparison
NSPR vs ONCY Comparison
Compare NSPR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- ONCY
- Stock Information
- Founded
- NSPR 2005
- ONCY 1998
- Country
- NSPR United States
- ONCY Canada
- Employees
- NSPR N/A
- ONCY N/A
- Industry
- NSPR Medical/Dental Instruments
- ONCY Pharmaceuticals and Biotechnology
- Sector
- NSPR Health Care
- ONCY Health Care
- Exchange
- NSPR Nasdaq
- ONCY Nasdaq
- Market Cap
- NSPR 99.7M
- ONCY 89.7M
- IPO Year
- NSPR N/A
- ONCY 1999
- Fundamental
- Price
- NSPR $1.81
- ONCY $1.02
- Analyst Decision
- NSPR Strong Buy
- ONCY Strong Buy
- Analyst Count
- NSPR 2
- ONCY 5
- Target Price
- NSPR $4.50
- ONCY $5.00
- AVG Volume (30 Days)
- NSPR 119.5K
- ONCY 966.3K
- Earning Date
- NSPR 11-04-2025
- ONCY 11-07-2025
- Dividend Yield
- NSPR N/A
- ONCY N/A
- EPS Growth
- NSPR N/A
- ONCY N/A
- EPS
- NSPR N/A
- ONCY N/A
- Revenue
- NSPR $7,779,000.00
- ONCY N/A
- Revenue This Year
- NSPR $7.48
- ONCY N/A
- Revenue Next Year
- NSPR $104.39
- ONCY N/A
- P/E Ratio
- NSPR N/A
- ONCY N/A
- Revenue Growth
- NSPR 14.04
- ONCY N/A
- 52 Week Low
- NSPR $1.77
- ONCY $0.33
- 52 Week High
- NSPR $3.80
- ONCY $1.51
- Technical
- Relative Strength Index (RSI)
- NSPR 22.72
- ONCY 37.21
- Support Level
- NSPR $2.05
- ONCY $0.92
- Resistance Level
- NSPR $2.40
- ONCY $1.05
- Average True Range (ATR)
- NSPR 0.15
- ONCY 0.08
- MACD
- NSPR -0.03
- ONCY -0.02
- Stochastic Oscillator
- NSPR 29.05
- ONCY 25.00
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.